Final Overall Survival and Other Efficacy and Safety Results From ASCEND-3: Phase II Study of Ceritinib in ALKi-Naive Patients With ALK-Rearranged NSCLC
Journal
Journal of Thoracic Oncology
Journal Volume
15
Journal Issue
4
Pages
609-617
Date Issued
2020
Author(s)
Nishio M.
Felip E.
Orlov S.
Park K.
Tsai C.-M.
Cobo M.
McKeage M.
Su W.-C.
Mok T.
Scagliotti G.V.
Spigel D.R.
Viraswami-Appanna K.
Chen Z.
Passos V.Q.
Shaw A.T.
Publisher
Elsevier Inc
Type
conference paper